Doctors inject synthetically developed molecules, similar to the natural joint liquid, into an arthritic joint. Viscosupplementation is, therefore, a choice when treating sufferers with glenohumeral joint osteoarthritis. The U.S. Meals and Drug Administration considers viscosupplementation an implant. While they approved the use of this process for treating knees in 1997, they have not really yet approved this treatment for use in shoulders. Surgeons should routinely take preventive actions to reduce the risk of potentially catastrophic problems caused by blood clots during and immediately following surgery.What: News briefing with live webcast from ASTRO’s 51st Annual Meeting. Study results previewed: Adding proton therapy ‘boost’ to X-ray radiation therapy reduces prostate tumor recurrences. Proton therapy is usually well-tolerated in prostate malignancy individuals. Where: McCormick Place West, Room 176b/c or on the Web at News briefing 4 When: Tuesday, November 3, at 12:00 p.m. ; 1:00 p.m. What: News briefing with live webcast from ASTRO’s 51st Annual Meeting. Study results previewed: Shorter radiation course stops cancer development in high-risk prostate cancers patients. Shorter radiation course as effective as regular therapy for prostate cancers recurrence. Where: McCormick Place West, Area 176b/c, or on the internet at How: To participate in the webcasts, click on the links above to view slides and pay attention to the audio of the conference live over the Internet.
Aid agencies threaten to keep Afghanistan seeing that President Karzai orders personal security firms to dissolve ‘Companies and aid companies implementing hundreds of millions of dollars in U.S.-funded projects here say they are preparing to leave Afghanistan unless President Hamid Karzai amends a decree that outlaws their personal security protection,’ the Wall Street Journal reports.